Proteomics & Protein Research
News on protein analysis, clinical proteomics, biomarkers in genetics, genomics, and molecular diagnostics.
At the company’s London Calling user meeting this week, Chief Technology Officer Clive Brown announced early proof of concept for nanopore protein sequencing.
CellCarta Acquires Rights to Targeted Protein Assays from Fred Hutch Spinout Precision Assays
Precision Assays' immune-MRM mass spectrometry assays use antibody enrichment of protein targets followed by mass spec analysis to quantify proteins of interest.
Supported by the Wellcome Trust, the effort is rooted in the idea that many proteins go unstudied due to a lack of basic functional information about them.
The firm also spoke about the need to interact with the FDA to clarify how to get its SomaSignal assay for cardiovascular events into clinical trials.
SomaLogic Q1 Revenues Grow 22 Percent
The Boulder, Colorado-based protein analysis company missed the consensus Wall Street revenue estimate but beat it on the bottom line.